Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Editorial Volume 4 Issue 3

Survey of HAART/ART in HIV/AIDS Patients

Rajeev R Shah1*, Tracy William2, Apoorwa Gupta3

1Professor and Head, Microbiology Department, PMCH, Udaipur, India
2William Dental Clinic, Peris, France
3Apollo Hospital, Indore, India

*Corresponding Author: Rajeev R Shah, Professor and Head, Microbiology Department, PMCH, Udaipur, India.

Received: December 24, 2019; Published: February 01, 2020

×

  The Human Immunodeficiency Virus (HIV) has changed from life threatening to chronic condition due to the almost universal use and accessibility of antiretroviral treatment (ART) among HIV patients. Antiretroviral (ARV) treatment works by suppressing the viral load and restoring the immune system. Once patients start Highly Active Antiretroviral Therapy (HAART), it is to be continued lifelong in spite of its many adverse side effects. Zidovudine (AZT) a nucleoside reverse transcriptase inhibitor is the first line antiretroviral regimen in India, and was the first break through in AIDS therapy in 1990. It is known to be associated with life threatening toxicity like anaemia.

×

References

×

Citation

Citation: Rajeev R Shah., et al. “Survey of HAART/ART in HIV/AIDS Patients". Acta Scientific Pharmaceutical Sciences 4.3 (2020): 01.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Last Date to Submit Articles
    Journal accepting all the types of Articles for upcoing issue by on/before July 30, 2025
  • Issue of Publication Certificate
    Publication Certificate will be issued to the author after Online publication of an Article
  • Best Article
    One Article will be selected as Best Article from all the Articles of the corresponding Issue, once the issue released, and honored with A Best Article Certificate

Contact US